P3 Health Partners financials
$6.54−5.76%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $386.4M | $386.4M | $384.8M | $345.3M | $355.8M | $373.2M | $370.7M | $362.1M | $379.2M | $388.5M | $346.9M | $288.4M |
| Gross profit | $86.0M | $50.4M | -$41.2M | -$24.5M | $4.4M | $1.2M | -$39.5M | -$39.8M | $14.0M | $6.4M | $346.9M | $288.4M |
| Gross margin | 22.3% | 13.0% | −10.7% | −7.1% | 1.2% | 0.3% | −10.7% | −11.0% | 3.7% | 1.7% | 100.0% | 100.0% |
| Operating income | $41.2M | $8.2M | -$153.9M | -$44.2M | -$34.1M | -$38.1M | -$138.5M | -$107.0M | -$31.3M | -$43.8M | -$64.3M | -$33.8M |
| Net income | -$2.1M | $1.2M | -$75.5M | -$31.6M | -$20.4M | -$20.5M | -$58.6M | -$46.5M | -$12.0M | -$18.7M | -$25.5M | -$13.3M |
| Net margin | −0.6% | 0.3% | −19.6% | −9.1% | −5.7% | −5.5% | −15.8% | −12.8% | −3.2% | −4.8% | −7.3% | −4.6% |
| Diluted EPS | $-0.63 | $0.32 | $-23.02 | $-9.67 | $-6.23 | $-6.28 | $-17.95 | $-15.70 | $-7.37 | $-7.86 | $-1.78 | $-6.00 |
| EBITDA | $62.3M | $29.3M | -$132.9M | -$23.2M | -$13.0M | -$17.0M | -$109.3M | -$85.3M | -$9.6M | -$22.3M | -$42.6M | -$12.1M |
| Operating cash flow | -$61.9M | -$27.5M | -$25.7M | -$15.4M | -$16.6M | -$33.5M | -$57.2M | -$22.6M | -$10.2M | -$20.0M | -$15.9M | -$7.5M |
| Free cash flow | -$61.9M | -$27.5M | -$25.9M | -$15.5M | -$16.6M | -$33.5M | -$57.2M | -$22.6M | -$10.2M | -$20.0M | -$16.1M | -$7.9M |
| Diluted shares | 3.4M | 8.4M | 3.3M | 3.3M | 3.3M | 3.3M | 3.3M | 3.3M | 2.8M | 2.4M | 14.3M | 6.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $21.3M | $25.5M | $25.0M | $37.7M | $38.6M | $40.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $120.3M | $311.8M | $273.4M | $560.3M | $209.3M | $184.3M |
| Total assets | $654.4M | $674.2M | $656.6M | $683.6M | $731.6M | $783.9M |
| Total liabilities | $516.7M | $807.3M | $796.9M | $664.6M | $644.4M | $662.8M |
| Shareholders' equity | $73.2M | -$143.5M | -$155.2M | -$18.7M | $44.5M | $63.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology